Literature DB >> 2539428

Circulating anti-neutrophil cytoplasm antibodies in patients with rapidly progressive glomerulonephritis and extracapillary proliferation.

L Nässberger1, A G Sjöholm, P Bygren, H Thysell, M Højer-Madsen, N Rasmussen.   

Abstract

We investigated 39 patients with rapidly progressive glomerulonephritis and extracapillary proliferation for the presence of circulating anti-neutrophil cytoplasm antibodies (ANCA) by indirect immunofluorescence. Patients with antibodies against the glomerular basement membrane, systemic lupus erythematosus or with glomerulonephritis following infection and where renal disease could be ascribed to treatment with drugs were not included. IgG class ANCA producing diffuse cytoplasmic immunostaining were detected in 54% of the patients. With reservation for the difficulties involved in distinguishing between different forms of systemic vasculitis, these autoantibodies were present in patients with Wegener's granulomatosis (12 out of 17 patients), polyarteritis nodosa (4/6), idiopathic extracapillary glomerulonephritis (1/4), and with less distinct syndromes (4/10), but not in Henoch-Schönlein's purpura (0/2). Another 18% of the patients showed granulocyte-specific anti-nuclear antibodies' with perinuclear immunostaining. This pattern was recently reported to indicate the presence of antibody against myeloperoxidase of alcohol-fixed neutrophils. Autoimmune mechanisms, particularly those involving components of neutrophil granulocytes, could play a significant role in development of extracapillary glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539428     DOI: 10.1111/j.1365-2796.1989.tb00062.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  7 in total

Review 1.  Antineutrophil cytoplasmic antibody--a useful serological marker for vasculitis.

Authors:  J A Goeken
Journal:  J Clin Immunol       Date:  1991-07       Impact factor: 8.317

2.  IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis.

Authors:  L S Jeffs; C A Peh; A Nelson; P G Tan; E Davey; K Chappell; G B Perkins; P R Hurtado
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

3.  Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.

Authors:  J M Clain; A M Hummel; J H Stone; F C Fervenza; G S Hoffman; C G M Kallenberg; C A Langford; W J McCune; P A Merkel; P A Monach; P Seo; R F Spiera; E W St Clair; S R Ytterberg; U Specks
Journal:  Clin Exp Immunol       Date:  2017-02-07       Impact factor: 4.330

4.  Long-term clinical course in acute crescentic glomerulonephritis.

Authors:  D Bach; K Hauser; B Grabensee
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

5.  The absence of anti-neutrophil cytoplasmic antibodies in patients with Henoch-Schönlein purpura.

Authors:  W L Robson; A K Leung; R C Woodman
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

6.  Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus.

Authors:  L Nässberger; A G Sjöholm; H Jonsson; G Sturfelt; A Akesson
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

7.  Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome.

Authors:  A M Cilursu; J Goeken; R R Olson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.